GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » VolitionRX Ltd (AMEX:VNRX) » Definitions » Shiller PE Ratio

VolitionRX (VolitionRX) Shiller PE Ratio : (As of May. 16, 2024)


View and export this data going back to 2007. Start your Free Trial

What is VolitionRX Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


VolitionRX Shiller PE Ratio Historical Data

The historical data trend for VolitionRX's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VolitionRX Shiller PE Ratio Chart

VolitionRX Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

VolitionRX Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of VolitionRX's Shiller PE Ratio

For the Diagnostics & Research subindustry, VolitionRX's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VolitionRX's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, VolitionRX's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where VolitionRX's Shiller PE Ratio falls into.



VolitionRX Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

VolitionRX's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, VolitionRX's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.11/129.4194*129.4194
=-0.110

Current CPI (Dec. 2023) = 129.4194.

VolitionRX Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.180 99.695 -0.234
201406 0.060 100.560 0.077
201409 -0.440 100.428 -0.567
201412 -0.050 99.070 -0.065
201503 -0.120 99.621 -0.156
201506 -0.100 100.684 -0.129
201509 -0.160 100.392 -0.206
201512 -0.150 99.792 -0.195
201603 -0.130 100.470 -0.167
201606 -0.130 101.688 -0.165
201609 -0.150 101.861 -0.191
201612 -0.120 101.863 -0.152
201703 -0.130 102.862 -0.164
201706 -0.130 103.349 -0.163
201709 -0.150 104.136 -0.186
201712 -0.150 104.011 -0.187
201803 -0.170 105.290 -0.209
201806 -0.150 106.317 -0.183
201809 -0.140 106.507 -0.170
201812 -0.110 105.998 -0.134
201903 -0.120 107.251 -0.145
201906 -0.110 108.070 -0.132
201909 -0.100 108.329 -0.119
201912 -0.080 108.420 -0.095
202003 -0.140 108.902 -0.166
202006 -0.120 108.767 -0.143
202009 -0.090 109.815 -0.106
202012 -0.110 109.897 -0.130
202103 -0.120 111.754 -0.139
202106 -0.100 114.631 -0.113
202109 -0.130 115.734 -0.145
202112 -0.150 117.630 -0.165
202203 -0.140 121.301 -0.149
202206 -0.140 125.017 -0.145
202209 -0.140 125.227 -0.145
202212 -0.130 125.222 -0.134
202303 -0.150 127.348 -0.152
202306 -0.140 128.729 -0.141
202309 -0.110 129.860 -0.110
202312 -0.110 129.419 -0.110

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VolitionRX  (AMEX:VNRX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


VolitionRX Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of VolitionRX's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


VolitionRX (VolitionRX) Business Description

Traded in Other Exchanges
N/A
Address
1489 West Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Executives
Eight Corp Ltd 10 percent owner C/O CROWE MORGAN, 8 ST. GEORGE'S STREET, DOUGLAS Y8 IM1 1AH
Salvatore Thomas Butera director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Rodney Gerard Rootsaert director, officer: SECRETARY 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Cameron John Reynolds director, officer: PRESIDENT AND CEO 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Guy Archibald Innes director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Edward Futcher director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Phillip Barnes director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Martin Charles Faulkes director 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Mickie Henshall director 1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON NV 89014
Jacob Vincent Micallef officer: Chief Scientific Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Michel Gaetan other: Manager Belgian Volition SPRL 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Jasmine Kway other: CEO-Singapore Volition 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Nicholas Plummer officer: GC - Volition Diagnostics 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014
Ann-louise Batchelor officer: Group Chief Marketing Officer 1489 WEST WARM SPRINGS ROAD,, SUITE 110, HENDERSON NV 89014
Terrell Jason Bradley Md officer: Chief Medical Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON NV 89014